3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
4
Prostatic Neoplasms
3
Glioma
3
Wilms Tumor
2
Lung Neoplasms
2
Glioblastoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Brain Neoplasms
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma of Lung
2
Solitary Fibrous Tumor, Pleural
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neuroblastoma
1
Neoplasms
1
Metastatic Malignant Female Reproductive System Neoplasm
1
Mesothelioma, Malignant
1
Head and Neck Neoplasms
1
Germinoma
1
Ganglioneuroblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Ependymoma
1
Down Syndrome
1
Diabetes Insipidus
1
Central Nervous System Nongerminomatous Germ Cell Tumor
1
Central Nervous System Neoplasms
1
Interventions
Doxorubicin
5
pembrolizumab
4
Specimen Handling
4
Radiotherapy
4
Radiation
4
Nivolumab
4
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
CTLA-4 Antigen
3
Biopsy
3
cabozantinib
2
Ifosfamide
2
tremelimumab
1
talimogene laherparepvec
1
regorafenib
1
peposertib
1
pazopanib
1
olaratumab
1
liposomal doxorubicin
1
futibatinib
1
fludarabine
1
eribulin
1
durvalumab
1
avelumab
1
aldesleukin
1
X-Rays
1
Trabectedin
1
Standard of Care
1
Quality of Life
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Radiotherapy, Conformal
×
1 year
×
Clear all
No trials found.